BioGaia AB (publ)
BGLAF
$8.87
-$0.8517-8.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.01M | 33.21M | 31.96M | 37.83M | 35.10M |
| Total Depreciation and Amortization | 2.44M | 2.41M | 2.40M | 2.28M | 2.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.41M | 4.45M | 8.39M | 3.97M | 2.97M |
| Change in Net Operating Assets | -2.30M | -4.87M | -5.55M | -7.33M | -4.84M |
| Cash from Operations | 33.56M | 35.21M | 37.20M | 36.75M | 35.54M |
| Capital Expenditure | -536.80K | -1.32M | -2.63M | -3.18M | -5.30M |
| Sale of Property, Plant, and Equipment | 7.40K | 7.40K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -38.50K | -36.80K | -5.60K | -7.10K | -8.90K |
| Cash from Investing | -567.80K | -1.35M | -2.63M | -3.19M | -5.31M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.87M | -9.36M | -10.04M | -9.55M | -10.09M |
| Issuance of Common Stock | 20.82M | 20.82M | 20.82M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -65.17M | -65.17M | -65.17M | -65.17M | -27.83M |
| Other Financing Activities | -509.31M | -509.31M | -155.22M | -150.82M | -150.82M |
| Cash from Financing | -64.43M | -64.48M | -64.96M | -66.49M | -29.19M |
| Foreign Exchange rate Adjustments | -384.00K | 966.60K | -770.40K | -830.10K | -271.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.82M | -29.65M | -31.17M | -33.75M | 767.10K |